Richard Valeix

Company: Telix Pharmaceuticals

Job title: President, Europe, Middle East and Africa (EMEA)

Seminars:

Panel Discussion: Review of the Last 12 Months of Development of Alpha Emitting Therapies 5:30 pm

Discuss how Lutathera has changed the game for RLT developers and what it has taught us about RLT’s place on the wider oncology field Explore what key learnings have been uncovered by VISION trial and other recent analyses of alphaemitters’ clinical applicationsRead more

day: Day Two